- Home
- EVAX vs ILAG Comparison
EVAX vs ILAG Comparison
Compare EVAX & ILAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- ILAG
- Stock Information
- Founded
- EVAX 2008
- ILAG 1981
- Country
- EVAX Denmark
- ILAG Hong Kong
- Employees
- EVAX N/A
- ILAG N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- ILAG Office Equipment/Supplies/Services
- Sector
- EVAX Health Care
- ILAG Consumer Discretionary
- Exchange
- EVAX Nasdaq
- ILAG Nasdaq
- Market Cap
- EVAX 16.3M
- ILAG 14.4M
- IPO Year
- EVAX 2021
- ILAG 2022
- Fundamental
- Price
- EVAX $2.53
- ILAG $0.83
- Analyst Decision
- EVAX Strong Buy
- ILAG
- Analyst Count
- EVAX 3
- ILAG 0
- Target Price
- EVAX $33.33
- ILAG N/A
- AVG Volume (30 Days)
- EVAX 6.8M
- ILAG 12.4K
- Earning Date
- EVAX 03-26-2025
- ILAG 04-14-2025
- Dividend Yield
- EVAX N/A
- ILAG N/A
- EPS Growth
- EVAX N/A
- ILAG N/A
- EPS
- EVAX N/A
- ILAG N/A
- Revenue
- EVAX $3,295,000.00
- ILAG $8,980,747.00
- Revenue This Year
- EVAX $9,039.73
- ILAG N/A
- Revenue Next Year
- EVAX $1.47
- ILAG N/A
- P/E Ratio
- EVAX N/A
- ILAG N/A
- Revenue Growth
- EVAX N/A
- ILAG 33.03
- 52 Week Low
- EVAX $2.22
- ILAG $0.35
- 52 Week High
- EVAX $22.05
- ILAG $1.35
- Technical
- Relative Strength Index (RSI)
- EVAX 40.91
- ILAG 49.70
- Support Level
- EVAX $2.43
- ILAG $0.73
- Resistance Level
- EVAX $2.80
- ILAG $0.84
- Average True Range (ATR)
- EVAX 0.31
- ILAG 0.08
- MACD
- EVAX 0.07
- ILAG 0.01
- Stochastic Oscillator
- EVAX 16.94
- ILAG 79.70
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About ILAG Intelligent Living Application Group Inc.
Intelligent Living Application Group Inc is engaged in the business of manufacturing and selling mechanical locksets. The business is spread across the Unites States, Canada, Australia, and China. Majority of the revenue is generated from the United States.